Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12441175rdf:typepubmed:Citationlld:pubmed
pubmed-article:12441175lifeskim:mentionsumls-concept:C0012063lld:lifeskim
pubmed-article:12441175lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:12441175lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:12441175lifeskim:mentionsumls-concept:C0077394lld:lifeskim
pubmed-article:12441175lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:12441175pubmed:dateCreated2002-11-20lld:pubmed
pubmed-article:12441175pubmed:abstractTextSeveral categories of neuromuscular blocking bisquaternary tropine and tropane derivatives were synthesized and studied in the past five decades, mainly with the purpose of arriving at meaningful information about structure-activity relationships. Such a structure-activity relationship database is important in the development of new muscle relaxants with improved pharmacological characteristics. Although quaternary tropine diesters were explored since 1952, most of them were developed in the last decade. Over 250 such agents are being reviewed here. The skeleton of the majority of them consists of two tropines, connected through their 3-OH group with various dicarboxylic acid ester linkages and quaternized by several mostly di- and trisubstituted benzyl groups. The significance of changing the quaternizing group; the diester linker; and, to a smaller extent, the substituents and their steric orientation on the tropane ring and some alterations of the tropane ring itself have been explored in in vivo experiments on anesthetized rats. Di- or trisubstituted alkoxy and/or acyloxybenzyl quaternaries of certain tropinyl diesters, e.g., glutaryl, fumaryl, and cyclobutane-1,2-dicarboxylyl, showed an optimal profile with respect to desirable neuromuscular blocking actions and side effects, which was confirmed on other experimental animal species. The details of the structural changes toward obtaining new ultrashort-acting nondepolarizing muscle relaxants are discussed.lld:pubmed
pubmed-article:12441175pubmed:languageenglld:pubmed
pubmed-article:12441175pubmed:citationSubsetIMlld:pubmed
pubmed-article:12441175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12441175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12441175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12441175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12441175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12441175pubmed:statusMEDLINElld:pubmed
pubmed-article:12441175pubmed:authorpubmed-author:GyermekLaszlo...lld:pubmed
pubmed-article:12441175pubmed:ownerNLMlld:pubmed
pubmed-article:12441175pubmed:authorsCompleteYlld:pubmed
pubmed-article:12441175pubmed:pagination1-21lld:pubmed
pubmed-article:12441175pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12441175pubmed:articleTitleStructure-activity relationships among derivatives of dicarboxylic acid esters of tropine.lld:pubmed
pubmed-article:12441175pubmed:affiliationDepartment of Anesthesiology, Harbor-University of California Los Angeles Medical Center, Box 10, 1000 W Carson Street, Torrance, CA 90502, USA. laslogy@earthlink.netlld:pubmed